• EHS: Professor Wim Schreurs, who are you, and how can you introduce yourself as an Orthopaedic Surgeon?
I was born in the eastern part of the Netherlands and after finishing high school I first studied Physical Therapy. Next, I decided to study Medicine at Nijmegen University. In 1988, after obtaining my medical degree I started working on my PhD thesis under the supervision of Professor Tom Slooff and Professor Rik Huiskes.
The focus of my thesis was on bone impaction grafting. Acetabular bone impaction grafting was started by Tom Sloof in 1979, so we have nowadays more than 40 years’ experience on the cups side. In 1987 in Nijmegen we performed some partial femoral bone impaction graftings using the Voorhoeve mesh, but the Exeter group were the first who started bone impaction grafting in a more regular way. However, they missed an instrumented system to perform reproducible femoral bone impaction grafting. In fact in Nijmegen we developed the principle of the technique of femoral bone impaction grafting as part of my thesis work. The system was tested in goats, both in vitro and in vivo. Based on the experimental work in Nijmegen and the clinical expertise in Exeter (Professor Robin Ling and Mr Graham Gie) the X-Change femoral bone impaction system was developed together with Howmedica in 1991. This system is still on the market, after the merge of Howmedica and Stryker 2001 it is now marketed by Stryker.
In 1990 I started my training as orthopedic resident which I finished in 1995. Subsequently I was asked to become faculty member of the Department of Orthopedics of the Radboud Medical Centre, Nijmegen, the Netherlands. I was very honored to become the successor of Professor Slooff in this Department and my career focused on hip pathology. My colleague in the Hip Line was Jean Gardeniers for a long time, and since his retirement in 2014 my current colleague has been Wim Rijnen. With both surgeons I have (had) a very pleasant work relationship, making running the daily practice really enjoyable.
• EHS: Do you also get involved in scientific matters and clinical research in Orthopaedics?
Working in an academic center, I had the opportunity to perform scientific work. In 1994, I defended my thesis. Thereafter, with many co-authors, the work initially was focused on the basis science of bone impaction grafting. At that time, we had a research group made up of both of biologists (Professor Buma) and biomechanics (Professor Verdonschot). In around 2005 we decided to focus more on the clinical outcomes of total hips in young patients, complex revisions and infections.
We now have a local data base that includes more than 1100 patients who have all had a total hip under the age of 50 years. Both in young patients and in revision cases we always try to reconstruct the damaged bone stock using bone impaction grafting. We have the philosophy that certainly in young patients, reconstruction of bone stock is mandatory. We have to accept that in young patients’ revision will occur and it is the bone stock quality that facilitates future revisions. We have published many clinical studies on these topics; the total number of PubMed publications on bone impaction grafting is more than 100.
Recently, I was appointed as Professor at the Radboud University and Radboud Medical Centre on behalf of the LROI, the Dutch Implant Registry set up by Dutch orthopedic surgeons in 2007. I am really honored to serve the NOV (the Netherlands Orthopedic Association) and the LROI for the coming years and this opportunity fits perfectly into my career.
• What about your involvement in the European Hip Society, and the next International Congress in 2020 taking place in Lille, France?
As many of you know, I have been part of the ExCom of the European Hip Society for nearly 6 years now. I have served as incoming President from 2014 to 2016, was President from 2016 to 2018 and now I will end my term in ExCom in Lille in 2020 as the Past President.
Under my supervision, the EHS International Congress in the Hague, the Netherlands, was organized from 20 to 22 September and I know that setting up such an event can only be done with the help of many. In the Netherlands I was lucky having both the support of experienced colleagues in my Department as well as the Intercongress organization.
I have no doubt that the meeting in France will be a big success. The bi-annual congress of the European Hip Society is a unique possibility for orthopedic surgeons to get the latest insight in diagnosing hip problems as well as the newest or the best proven methods and techniques. I have also no doubt that the number of attendees we had at the Dutch meeting in 2018 (with more than 900 visitors - already very successful) will be reached by the Lille meeting. It is the meeting to meet your hip surgeon fellows and extend your international connections. You will see there many surgeons from Europe, however the congress becomes more and more internationally recognized with visitors from all over the world.
Hope to see you all there at the EHS 14th Congress, enjoying both the congress and of course the fantastic city of Lille.